These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 19150099)

  • 1. [Classification of parkinsonian syndromes via factorial discriminant analysis of brain SPECT data].
    Kreisler A; Defebvre L; Duhamel A; Lecouffe P; Dujardin K; Steinling M; Pasquier F; Destée A
    Rev Neurol (Paris); 2009 May; 165(5):440-8. PubMed ID: 19150099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discriminating among degenerative parkinsonisms using advanced (123)I-ioflupane SPECT analyses.
    Badoud S; Van De Ville D; Nicastro N; Garibotto V; Burkhard PR; Haller S
    Neuroimage Clin; 2016; 12():234-40. PubMed ID: 27489771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corticobasal degeneration and Parkinson's disease assessed by HmPaO SPECT: the utility of factorial discriminant analysis.
    Kreisler A; Defebvre L; Lecouffe P; Duhamel A; Charpentier P; Steinling M; Destée A
    Mov Disord; 2005 Nov; 20(11):1431-8. PubMed ID: 16007659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topography of dopamine transporter availability in progressive supranuclear palsy: a voxelwise [123I]beta-CIT SPECT analysis.
    Seppi K; Scherfler C; Donnemiller E; Virgolini I; Schocke MF; Goebel G; Mair KJ; Boesch S; Brenneis C; Wenning GK; Poewe W
    Arch Neurol; 2006 Aug; 63(8):1154-60. PubMed ID: 16908744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance imaging-based volumetry differentiates progressive supranuclear palsy from corticobasal degeneration.
    Gröschel K; Hauser TK; Luft A; Patronas N; Dichgans J; Litvan I; Schulz JB
    Neuroimage; 2004 Feb; 21(2):714-24. PubMed ID: 14980574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiating between progressive supranuclear palsy and corticobasal degeneration by brain perfusion SPET.
    Zhang L; Murata Y; Ishida R; Saitoh Y; Mizusawa H; Shibuya H
    Nucl Med Commun; 2001 Jul; 22(7):767-72. PubMed ID: 11453049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FDG PET in the differential diagnosis of parkinsonian disorders.
    Eckert T; Barnes A; Dhawan V; Frucht S; Gordon MF; Feigin AS; Eidelberg D
    Neuroimage; 2005 Jul; 26(3):912-21. PubMed ID: 15955501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain perfusion differences in parkinsonian disorders.
    Kimura N; Hanaki S; Masuda T; Hanaoka T; Hazama Y; Okazaki T; Arakawa R; Kumamoto T
    Mov Disord; 2011 Dec; 26(14):2530-7. PubMed ID: 21830234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 123I-FP-CIT in progressive supranuclear palsy and in Parkinson's disease: a SPECT semiquantitative study.
    Filippi L; Manni C; Pierantozzi M; Brusa L; Danieli R; Stanzione P; Schillaci O
    Nucl Med Commun; 2006 Apr; 27(4):381-6. PubMed ID: 16531926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Technetium HMPAO SPECT study in dementia with Lewy bodies, Alzheimer's disease and idiopathic Parkinson's disease.
    Defebvre LJ; Leduc V; Duhamel A; Lecouffe P; Pasquier F; Lamy-Lhullier C; Steinling M; Destée A
    J Nucl Med; 1999 Jun; 40(6):956-62. PubMed ID: 10452310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease.
    Rizzo G; Martinelli P; Manners D; Scaglione C; Tonon C; Cortelli P; Malucelli E; Capellari S; Testa C; Parchi P; Montagna P; Barbiroli B; Lodi R
    Brain; 2008 Oct; 131(Pt 10):2690-700. PubMed ID: 18819991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [¹⁸F]FDG-PET is superior to [¹²³I]IBZM-SPECT for the differential diagnosis of parkinsonism.
    Hellwig S; Amtage F; Kreft A; Buchert R; Winz OH; Vach W; Spehl TS; Rijntjes M; Hellwig B; Weiller C; Winkler C; Weber WA; Tüscher O; Meyer PT
    Neurology; 2012 Sep; 79(13):1314-22. PubMed ID: 22914831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Regional cerebral blood flow single photon emission tomography (SPECT) and magnetic resonance imaging (MRI) may be useful in the diagnosis of patients with cortico-basal degeneration, progressive supranuclear palsy and multiple system atrophy].
    Lass P; Sławek J; Derejko M; Dubaniewicz M
    Neurol Neurochir Pol; 2003; 37 Suppl 5():263-74. PubMed ID: 15098354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is brain perfusion a differentiating feature in the comparison of Progressive Supranuclear Palsy Syndrome (PSPS) and Corticobasal Syndrome (CBS)?
    Alster P; Nieciecki M; Koziorowski D; Cacko A; Charzyńska I; Królicki L; Friedman A
    J Clin Neurosci; 2020 Jul; 77():123-127. PubMed ID: 32389545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual-tracer dopamine transporter and perfusion SPECT in differential diagnosis of parkinsonism using template-based discriminant analysis.
    Van Laere K; Casteels C; De Ceuninck L; Vanbilloen B; Maes A; Mortelmans L; Vandenberghe W; Verbruggen A; Dom R
    J Nucl Med; 2006 Mar; 47(3):384-92. PubMed ID: 16513606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multicenter assessment of dopamine transporter imaging with DOPASCAN/SPECT in parkinsonism. Parkinson Study Group.
    Neurology; 2000 Nov; 55(10):1540-7. PubMed ID: 11094111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of Parkinson's disease and related syndromes using 123I-IMP-SPECT with the ARG method].
    Kageyama H; Kikuchi S; Tashiro K
    Nihon Rinsho; 1997 Jan; 55(1):238-42. PubMed ID: 9014457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis of the literature on diagnostic accuracy of SPECT in parkinsonian syndromes.
    Vlaar AM; van Kroonenburgh MJ; Kessels AG; Weber WE
    BMC Neurol; 2007 Sep; 7():27. PubMed ID: 17764571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tc-99m ethylene cysteinate dimer SPECT in the differential diagnosis of parkinsonism.
    Feigin A; Antonini A; Fukuda M; De Notaris R; Benti R; Pezzoli G; Mentis MJ; Moeller JR; Eidelberg D
    Mov Disord; 2002 Nov; 17(6):1265-70. PubMed ID: 12465066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of the dopaminergic degeneration in Parkinson's disease with [123I] beta-CIT and SPECT. Correlation with clinical findings and comparison with multiple system atrophy and progressive supranuclear palsy.
    Brücke T; Asenbaum S; Pirker W; Djamshidian S; Wenger S; Wöber C; Müller C; Podreka I
    J Neural Transm Suppl; 1997; 50():9-24. PubMed ID: 9120429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.